Novai Investors
Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.
Headquarters:
Reading, Reading, United Kingdom
Founded Date:
2020
Industry:
Healthcare Company
Investor Type:
Healthcare Company

